Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mytify Junior
- Development stage
- Unknown
- Lead developer
- Goldline Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Mytify Junior is a pediatric multivitamin and multimineral syrup developed and marketed by Goldline Pharmaceutical. The formulation is designed to prevent and treat nutritional deficiencies, supporting overall growth, immune function, and metabolic health in children. It contains a combination of essential vitamins (including Vitamin A, Thiamine, Riboflavin, Pyridoxine, Folic Acid, D-Panthenol, Cyanocobalamin, and Vitamin E) and minerals (Elemental Calcium and Elemental Zinc) that serve as vital cofactors and nutrients in numerous physiological and metabolic processes.
- Brand names
- Mytify Junior
- Other names
- Mytify Junior Syrup
Beyond the preview
Go deeper on Mytify Junior.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mytify Junior.